Response of Vancomycin according to Steroid Dosage in Pediatric Patients with Culture-Proven Bacterial Meningitis

Area of Science:

• Pediatric Infectious Diseases
• Pharmacology
• Clinical Medicine

Background:

• Bacterial meningitis remains a significant cause of morbidity and mortality in pediatric populations.
• Vancomycin is a critical antibiotic for treating resistant bacterial meningitis.
• The role of concomitant steroid therapy in pediatric bacterial meningitis requires further elucidation.

Purpose of the Study:

• To evaluate the efficacy of combined vancomycin and steroid therapy for culture-proven bacterial meningitis in pediatric patients.
• To investigate the impact of steroid dosage on vancomycin treatment response.
• To assess alternative antibiotic strategies for patients unresponsive to vancomycin.

Main Methods:

• Retrospective analysis of 86 pediatric patients with culture-positive bacterial meningitis treated between 2005 and 2015.
• Focus on 10 patients who received vancomycin as first-line therapy, with all cultured bacteria sensitive to vancomycin.
• Examination of the relationship between steroid dosage (high vs. low) and vancomycin treatment effectiveness.

Main Results:

• Five out of ten patients did not respond to vancomycin.
• A significantly reduced response rate to vancomycin was observed with increasing steroid dosage (P = 0.035).
• Patients who did not respond to vancomycin with high-dose steroids showed clinical improvement after switching to teicoplanin.

Conclusions:

• Concomitant steroid use, particularly high doses, may diminish vancomycin efficacy in pediatric bacterial meningitis.
• Physicians should exercise caution when prescribing steroids alongside vancomycin.
• Close monitoring of steroid dosage and patient response is crucial for optimizing treatment outcomes.